Vanguard Global Advisers’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.13M Sell
35,733
-2,783
-7% -$685K ﹤0.01% 644
2026
Q2
$7.21M Sell
38,516
-2,412
-6% -$443K ﹤0.01% 691
2026
Q1
$7.72M Buy
+40,928
New +$8.62M ﹤0.01% 661

Other funds holding THC

Vanguard Global Advisers's THC Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Tenet Healthcare (THC) stake by 7.2% in Q3 2026, selling an estimated $685K and leaving 35,733 shares worth $9.13M. The position accounts for ﹤0.01% of the portfolio, ranked #644.

Vanguard Global Advisers first reported a position in THC in Q1 2026 and has held it in 3 quarters since. 635 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Vanguard Global Advisers held 35,733 shares of Tenet Healthcare worth $9.13M as of Q3 2026.
  • Vanguard Global Advisers sold 2,783 Tenet Healthcare shares in Q3 2026, an estimated $685K.
  • Tenet Healthcare made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #644 holding.
  • Vanguard Global Advisers first reported a position in Tenet Healthcare in Q1 2026 and has held it in 3 quarters since.
  • 635 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.